Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Arcellx and Kite Continue Progress with Advances in Anito-Cel Multiple Myeloma Program

Friday, May 10, 2024

Arcellx Inc and Kite a Gilead Company have jointly announced significant operational advancements in their collaborative effort on the anitocabtagene autoleucel program for multiple myeloma treatment

SN Bioscience Granted FDA Fast Track Status for Small Cell Lung Cancer Therapy

Friday, May 10, 2024

SN Bioscience Co Ltd under the leadership of CEO Park Younghwan made an announcement on May th regarding the FDAs decision to grant Fast Track Designation for SNB a novel polymer nanoparticle anticancer medication currently undergoing clinical trials...

ProQR Unveils Preclinical Proof of Concept Findings for AX-0810 Axiomerâ„¢ RNA Editing Initiative Targeting NTCP in Combatting Cholestatic Conditions

Thursday, May 09, 2024

ProQR Therapeutics NV revealed significant preclinical findings at the American Society of Gene Cell Therapy Annual Meeting in Baltimore Maryland Their proprietary Axiomer RNA editing

CytomX Therapeutics Shares Positive Phase 1a Dose Escalation Findings for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)

Thursday, May 09, 2024

CytomX Therapeutics Inc announced positive initial findings from the ongoing CX Phase a dose escalation clinical study The study focuses on CX a novel masked conditionally activated PROBODY

NSG BioLabs Drives Biotech Innovation in Singapore and Southeast Asia through EnterpriseSG and Merck Collaborations, Supported by Investments from Celadon Partners and ClavystBio

Wednesday, May 08, 2024

NSG BioLabs a prominent provider of biotech coworking laboratory and office spaces in Singapore

BioVersys Expands Collaboration with GSK and Boosts Series C Funding by CHF 12.3 Million

Wednesday, May 08, 2024

BioVersys AG a clinicalstage biopharmaceutical company and GSK plc a global biopharma leader have announced an expansion of their strategic collaboration

VYNE Therapeutics Receives FDA Clearance for IND Application of VYN202, a Unique BD2-Selective BET Inhibitor

Tuesday, May 07, 2024

VYNE Therapeutics Inc announced today that the US Food and Drug Administration has cleared its Investigational New Drug application for VYN an oral BDselective BET inhibitor

BioAtla Receives FDA Clearance for Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate Targeting Multiple Tumors

Tuesday, May 07, 2024

BioAtla Inc has received clearance from the US Food and Drug Administration to proceed with its investigational new drug application for BA an antibodydrug conjugate

Adcentrx Therapeutics Receives IND Clearance from China NMPA for ADRX-0706, a Novel Nectin-4 ADC Aimed at Advanced Solid Tumors

Tuesday, May 07, 2024

Adcentrx Therapeutics a prominent biotechnology firm specializing in advancing AntibodyDrug Conjugate therapies for cancer and other severe illnesses has shared significant news They announced that the China

Calliditas Announces Positive Topline Results from Phase 2 Trial of Setanaxib, its Lead NOX Inhibitor Candidate, in Head and Neck Cancer

Monday, May 06, 2024

Calliditas Therapeutics AB has unveiled significant findings from its Phase trial investigating setanaxib its primary NOX enzyme inhibitor in combination